Cycliq launches US version of online sales portal


Published 07-JUN-2017 12:09 P.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Leading distributor of combined high definition camera and lighting combinations for bicycles, Cycliq Group (ASX:CYQ) has launched a US version of its online sales portal which will allow independent bike dealers across America to purchase its products direct from the website at wholesale prices.

This will be the company’s second direct order solution following the launch of the Australian version earlier in the year, an initiative that has been the catalyst for sales growth in this country.

In keeping with the Australian version of the US online sales portal, it will provide bike retailers with an efficient ordering system that will improve engagement and brand awareness of CYQ and its products in the US market.

Of course, CYQ is still in its early stages and investors should seek professional financial advice if considering this stock foe their portfolio.

Launch of portal drives 14% sales growth in Australia

Discussing this development, group Executive Chairman Chris Singleton said, “Cycliq’s Australian portal is already having a positive impact with a significant uptake in dealer registrations in the last two months, prompting sales in Australia to increase by 14%”.

Singleton highlighted the fact that direct order portals form part of the company’s global distribution strategy, optimising sales of its safety and action camera products.

He noted that there are hundreds of independent bike stores in Australia, whereas in the United States there are thousands. Consequently, the traction that can be gained from this development in a much larger market such as the US is likely to be substantial.

Fleshing out the figures further, there are more than 3000 specialty bicycle retailers across the US according to the National Bicycle Dealer Association. While these retailers account for 13% of the bicycle market by unit sales they attract 49% of the total consumer spend.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free